En | De
Sie sind hier: Neurologie » Multiple Sklerose 02. Dezember 2020
Multiple Sklerose
Erweiterte Suche
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Multiple Sklerose
Neuromuskuläre Erkrankungen
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1547  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 30935  
Current and emerging disease modulatory therapies and treatment targets for multiple sclerosis.
J Intern Med
Piehl F.
PMID: 33258193 [PubMed - as supplied by publisher]

Author response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
Binzer S, Manouchehrinia A, Hillert J.
PMID: 33257518 [PubMed - in process]

Reader response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
Bsteh G, Berger T.
PMID: 33257517 [PubMed - in process]

Editors' note: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
Ganesh A, Galetta S.
PMID: 33257516 [PubMed - in process]

Quality of life in adults with multiple sclerosis: a systematic review.
BMJ Open
Gil-González I, Martín-Rodríguez A, Conrad R, Pérez-San-Gregorio MÁ.
PMID: 33257490 [PubMed - in process]

Positive association of herpes simplex virus-IgG with multiple sclerosis: A systematic review and meta-analysis.
Mult Scler Relat Disord
Xu L, Zhang LJ, Yang L, Yang CS, Yi M, Zhang SN, Wang N, Huang CN, Liu MQ.
PMID: 33254090 [PubMed - as supplied by publisher]

Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
Petrou P, Kassis I, Levin N, Paul F, Backner Y, Benoliel T, Oertel FC, Scheel M, Hallimi M, Yaghmour N, Hur TB, Ginzberg A, Levy Y, Abramsky O, Karussis D.
PMID: 33253391 [PubMed - as supplied by publisher]

Little evidence for an effect of smoking on multiple sclerosis risk: A mendelian randomization study.
PLoS Biol
Mitchell RE, Bates K, Wootton RE, Harroud A, Richards JB, Davey Smith G, Munafò MR.
PMID: 33253141 [PubMed - as supplied by publisher]

Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?
Drug Discov Today
Findling O, Sellner J.
PMID: 33248250 [PubMed - as supplied by publisher]

Altered astrocytic function in experimental neuroinflammation and multiple sclerosis.
das Neves SP, Sousa JC, Sousa N, Cerqueira JJ, Marques F.
PMID: 33247866 [PubMed - as supplied by publisher]

The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review.
Rammohan K, Coyle PK, Sylvester E, Galazka A, Dangond F, Grosso M, Leist TP.
PMID: 33247831 [PubMed - as supplied by publisher]

Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total antioxidant capacity, and 8-hydroxy-2'-deoxyguanosine in patients with multiple sclerosis.
Clin Neurol Neurosurg
Khajenobar NB, Mahboob S, Nourazarian A, Shademan B, Laghousi D, Moayed ZB, Hassanpour M, Nikanfar M.
PMID: 33246251 [PubMed - as supplied by publisher]

Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis.
J Mol Histol
Khalilian B, Madadi S, Fattahi N, Abouhamzeh B.
PMID: 33245472 [PubMed - as supplied by publisher]

Response to Letter to the Editor Regarding the Article Entitled "Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review".
Bogaardt H, Alali D, Ballard K.
PMID: 33245423 [PubMed - as supplied by publisher]

Vestibular rehabilitation in multiple sclerosis: study protocol for a randomised controlled trial and cost-effectiveness analysis comparing customised with booklet based vestibular rehabilitation for vestibulopathy and a 12 month observational cohort study of the symptom reduction and recurrence rate following treatment for benign paroxysmal positional vertigo.
BMC Neurol
Marsden J, Pavlou M, Dennett R, Gibbon A, Knight-Lozano R, Jeu L, Flavell C, Freeman J, Bamiou DE, Harris C, Hawton A, Goodwin E, Jones B, Creanor S.
PMID: 33243182 [PubMed - in process]

Are drugs for multiple sclerosis fatigue just placebos?
Lancet Neurol
Bourdette D.
PMID: 33242420 [PubMed - as supplied by publisher]

Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Lancet Neurol
Nourbakhsh B, Revirajan N, Morris B, Cordano C, Creasman J, Manguinao M, Krysko K, Rutatangwa A, Auvray C, Aljarallah S, Jin C, Mowry E, McCulloch C, Waubant E.
PMID: 33242419 [PubMed - as supplied by publisher]

Inflammatory Activity and Treatment Response in Pediatric Compared to Adult Multiple Sclerosis: A Pilot, Retrospective and Observational Study of the First Year After Diagnosis.
Acta Med Port
De Carvalho S, Pinto J, Correia I, Faustino R, Vasconcelos M, Sousa L, Palavra F.
PMID: 33241993 [PubMed - as supplied by publisher]

Impact of an Existential-Spiritual Intervention Compared with a Cognitive-Behavioral Therapy on Quality of Life and Meaning in Life among Women with Multiple Sclerosis.
Iran J Psychiatry
Hajibabaei M, Kajbaf B, Esmaeili M, Harirchian MH, Montazeri A.
PMID: 33240382 [PubMed]

Microglia Diversity in Health and Multiple Sclerosis.
Front Immunol
Zia S, Rawji KS, Michaels NJ, Burr M, Kerr BJ, Healy LM, Plemel JR.
PMID: 33240276 [PubMed - in process]

   Artikel 1 - 20 / 30935    Seite 1 von 1547  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.



mehr >>


Sky right 1